What does the evidence say about Selenium Hair Loss Randomized Trial?

The current Migaku evidence database contains 2 reusable source documents for Selenium Hair Loss Randomized Trial. This answer focuses on benefits, uncertainty, and practical interpretation. - This systematic review aimed to evaluate the role of maternal Se status during pregnancy in miscarriage risk. [Kyriakou SI (2026); evidence level 1] - Available evidence was qualitatively synthesized and predefined sources of bias were assessed. [Kyriakou SI (2026); evidence level 1] - Despite notable methodological limitations across several studies, current evidence indicates that maternal blood Se concentrations are lower among women who experience miscarriage compared to those with uncomplicated pregnancies. [Kyriakou SI (2026); evidence level 1] - Selenium (Se) is an antioxidant essential trace element influencing inflammatory and immune pathways. [Kyriakou SI (2026); evidence level 1] - Background/objectives Sensorineural hearing loss (SNHL) is a chronic condition with no established pharmacological treatment. [Mavandi M (2026); evidence level 3] Evidence levels are sorting aids, not final clinical grades. Level 1 usually indicates systematic-review style evidence, level 2 indicates randomized trials or public-health guidance, and lower levels need more cautious wording. This page is educational. People with medical conditions, pregnancy, medication use, or unusual symptoms should ask a qualified clinician before changing supplements, medication, or treatment routines.